Artificial intelligence (AI)-powered bibliometric analysis of global trends in mesenchymal stem cells (MSCs)-derived exosome research: 2014-2023.

Journal: BioMedicine
Published Date:

Abstract

INTRODUCTION: In recent years, significant progress has been made in regenerative medicine, specifically in using mesenchymal stem cells (MSCs) due to their regenerative and differentiating abilities. An exciting development in this area is the utilization of exosomes derived from MSCs, which have shown promise in tissue restoration, immune system modulation, and cancer treatment.

Authors

  • Shih-Chang Tsai
    Department of Biological Science and Technology, China Medical University, Taichung, Taiwan.
  • Bing-Han Wan
    Department of Biological Science and Technology, China Medical University, Taichung, Taiwan.
  • Fuu-Jen Tsai
    Million-Person Precision Medicine Initiative, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan.
  • Jai-Sing Yang
    Department of Medical Research, China Medical University Hospital, China Medical University, Taichung, Taiwan.

Keywords

No keywords available for this article.